Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
06 Mar 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201452
20 Sep 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/blueprint-medicines-reports-arrow-trial-data-at-esmo-virtual-congress-2020-demonstrating-durable-clinical-benefits-of-gavreto-pralsetinib-in-patients-with-advanced-ret-mutant-medullary-thyroid-cancer-301134311.html
29 Aug 2018
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-29-2018-1535509071.pdf
01 Aug 2018
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-1-2018-1533104328.pdf
01 Sep 2017
// ECONOMIC TIMES
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/arrow-pharma-acquires-australian-operations-of-amneal-pharma/articleshow/60311034.cms
09 Jun 2017
// Kate Aubusson SMH
http://www.smh.com.au/national/health/second-valium-manufacturer--arrow-recalls-medication-after-fears-of-tampering-at-sydney-factory-20170609-gwoklh.html
Regulatory Info :
Registration Country : Australia
Dosage Form : tablet
Brand Name : GLYBOSAY
Dosage Strength : 50 mg
Packaging : 90
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form : tablet
Brand Name : GLYBOSAY
Dosage Strength : 100 mg
Packaging : 90
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form : tablet
Brand Name : GLYBOSAY
Dosage Strength : 50 mg
Packaging : 90
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form : tablet
Brand Name : GLYBOSAY
Dosage Strength : 100 mg
Packaging : 90
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form : tablet
Brand Name : Diamox
Dosage Strength : 250 mg
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form : capsule
Brand Name : ZETIN
Dosage Strength : 10 mg
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form : capsule
Brand Name : ZETIN
Dosage Strength : 25 mg
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form :
Brand Name : Hadlima
Dosage Strength :
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form :
Brand Name : Hadlima
Dosage Strength :
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Dosage Form :
Brand Name : Hadlima
Dosage Strength :
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?